Aspect Biosystems

12:15 PM - 12:30 PM (PDT), Wednesday, June 15, 2022
Aspect Biosystems is a biotechnology company creating bioprinted therapeutics as medicines of the future. Aspect is applying its microfluidic 3D bioprinting technology internally to develop these advanced cell therapies and partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
British Columbia
Company HQ Country:
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Bioprinted pancreatic and liver tissue for metabolic indications
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Aspect Biosystems